|Name of Responsible Staff
||Dr. S.K. Sarin, Dr. Manoj Kumar, Dr. Ajeet Singh Bhadoria
|Type of Activity
||Collection; collation and dissemination of information
|Description of the activity
||Hospital based cohort studies on HBV and/or HCV positive individuals to evaluate acceptable (invasive versus non-invasive and cost-effective modalities for assessment and progression of hepatic fibrosis.
||To train clinicians and specialists in viral Hepatitis and Liver diseases. HIP:-
- To identify the factors influencing fibrosis development and progression in different cohorts and populations.
- Delineate appropriate evaluation tools for diagnosis and progression of Fibrosis
- Studies could be expanded to other countries and regions. WHO Dliverable (Top Task)Evidence-based data and policies for action to support WHO’s initiatives on assessment of hepatic fibrosis in relation to viral hepatitis.
|Name of funding sources
||ILBS, Government of NCT of Delhi and Government of India
|Activity Time Frame
||A 5 year prospective cohort study was planned and ethical approval was taken in Jan 2016. Data collection is ongoing